Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SNP genetic polymorphisms of MDR-1, CYP1A2 and CYPB11 genes in four canine breeds upon toxicological evaluation.

Journal of veterinary science - 1 Jan 2015

Gagliardi Rosa, Llambí Silvia, Arruga M Victoria

Abstract excerpt

The fields of pharmacogenetics and pharmacogenomics have become increasingly promising regarding the clinical application of genetic data to aid in prevention of adverse reactions. Specific screening tests can predict which animals express modified proteins or genetic sequences responsible for adverse effects associated with a drug. Among the genetic variations that have been investigated in dogs, the multidrug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to ATP Binding Cassette Transporter, Subfamily B, Member 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP1A2

Share to Cytochrome P450 Family 2

Share to Polymorphism, Single Nucleotide

Share to Steroid Hydroxylases

Source

Open in PubMed Open full text

Identifiers

PMID: 25797294
DOI: 10.4142/jvs.2015.16.3.273
PMCID: PMC4588012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SNP genetic polymorphisms of MDR-1, CYP1A2 and CYPB11 genes in four canine breeds upon toxicological evaluation.PMID 25797294Read ↗

Review of prevalence, genetic aspects and adverse effects of the mdr1-1Delta mutation in dogs.Semantic proximity Read ↗

The prevalence of ABCB1:c.227_230delATAG mutation in affected dog breeds from European countries.Semantic proximity Read ↗

Therapeutic implications of the MDR‐1 geneSemantic proximity Read ↗

Detection of the CYP1A2 1117C>T polymorphism in 14 dog breeds.Semantic proximity Read ↗

Breed distribution of the nt230(del4) MDR1 mutation in dogs.Semantic proximity Read ↗

Genetic variants in dog cytochrome P450 2B6 and their relevance to interindividual variability of oxidations of probe drug propofol.Semantic proximity Read ↗

Breed is associated with the ABCB1-1Δ mutation in Australian dogs.Semantic proximity Read ↗

Canine Cytochrome P-450 PharmacogeneticsSemantic proximity Read ↗

Breed distribution of the ABCB1-1Delta (multidrug sensitivity) polymorphism among dogs undergoing ABCB1 genotyping.Semantic proximity Read ↗

Genetic variants of cytochrome P450 2C21 identified by screening 6344 dogs influenced oxidations of the probe drug omeprazole.Semantic proximity Read ↗

Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.Semantic proximity Read ↗

Polymorphism of cytochrome P450 A2 (CYP1A2) in pure and mixed breed dogs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.